𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole

✍ Scribed by Carina Centerholt; Marianne Ekblom; Tomas Odergren; Olof Borgå; Gabriela Popescu; Karl-Heinz Molz; Andrea Couturier; Angelika Weil

Publisher
Springer
Year
2003
Tongue
English
Weight
226 KB
Volume
59
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steady-state pharmacokinetics of nefazod
Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function
✍ R. H. Barbhaiya; M. E. Brady; U. A. Shukla; D. S. Greene 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 604 KB

The steady-state pharmacokinetics of nefazodone (NEF) and its metabolites hydroxynefazodone (HO-NEF) and m-chlorophenylpiperazine (mCPP) were compared in subjects with normal and impaired renal function. Patients: The Study was of parallel group design which included 7 subjects with normal (NOR) ren

Single-dose pharmacokinetics of nefazodo
Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment
✍ R. H. Barbhaiya; D. S. Greene; U. A. Shukla 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 658 KB

The single-dose pharmacokinetics of nefazodone (NEF) and its metabolites hydroxynefazodone (HO-NEF) and m-chlorophenylpiperazine (mCPP) were examined in 12 healthy younger subjects < 55 years of age (YNG), 12 elderly subjects > 65 years of age (ELD), 12 patients with biopsy proven hepatic cirrhosis